56 related articles for article (PubMed ID: 15085288)
1. [Autocrine IL-1beta secretion leads to NF-kappabeta-mediated chemoresistance in pancreatic carcinoma cells in vivo].
Müerköster S; Arlt A; Gehrz A; Vorndamm J; Witt M; Grohmann F; Fölsch UR; Schäfer H
Med Klin (Munich); 2004 Apr; 99(4):185-90. PubMed ID: 15085288
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
3. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.
Arlt A; Vorndamm J; Müerköster S; Yu H; Schmidt WE; Fölsch UR; Schäfer H
Cancer Res; 2002 Feb; 62(3):910-6. PubMed ID: 11830551
[TBL] [Abstract][Full Text] [Related]
4. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta.
Müerköster S; Wegehenkel K; Arlt A; Witt M; Sipos B; Kruse ML; Sebens T; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2004 Feb; 64(4):1331-7. PubMed ID: 14973050
[TBL] [Abstract][Full Text] [Related]
5. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.
Müerköster S; Arlt A; Witt M; Gehrz A; Haye S; March C; Grohmann F; Wegehenkel K; Kalthoff H; Fölsch UR; Schäfer H
Int J Cancer; 2003 Apr; 104(4):469-76. PubMed ID: 12584745
[TBL] [Abstract][Full Text] [Related]
6. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract][Full Text] [Related]
7. IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.
Zhuang Z; Ju HQ; Aguilar M; Gocho T; Li H; Iida T; Lee H; Fan X; Zhou H; Ling J; Li Z; Fu J; Wu M; Li M; Melisi D; Iwakura Y; Xu K; Fleming JB; Chiao PJ
Clin Cancer Res; 2016 Mar; 22(6):1432-44. PubMed ID: 26500238
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
9. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
10. Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases.
Müerköster SS; Lust J; Arlt A; Häsler R; Witt M; Sebens T; Schreiber S; Fölsch UR; Schäfer H
Oncogene; 2006 Jun; 25(28):3973-81. PubMed ID: 16474845
[TBL] [Abstract][Full Text] [Related]
11. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.
Geismann C; Grohmann F; Dreher A; Häsler R; Rosenstiel P; Legler K; Hauser C; Egberts JH; Sipos B; Schreiber S; Linkermann A; Hassan Z; Schneider G; Schäfer H; Arlt A
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):782-796. PubMed ID: 28188806
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
[TBL] [Abstract][Full Text] [Related]
15. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.
Ma Q; Wu X; Wu J; Liang Z; Liu T
Int J Oncol; 2017 Oct; 51(4):1104-1114. PubMed ID: 28902358
[TBL] [Abstract][Full Text] [Related]
16. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
Banerjee S; Zhang Y; Wang Z; Che M; Chiao PJ; Abbruzzese JL; Sarkar FH
Int J Cancer; 2007 Feb; 120(4):906-17. PubMed ID: 17131310
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo.
Usui N; Matsushima K; Pilaro AM; Longo DL; Wiltrout RH
Biotherapy; 1996; 9(4):199-208. PubMed ID: 9012539
[TBL] [Abstract][Full Text] [Related]
20. Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.
Huang CK; Yang CY; Jeng YM; Chen CL; Wu HH; Chang YC; Ma C; Kuo WH; Chang KJ; Shew JY; Lee WH
Oncogene; 2014 Jun; 33(23):2968-77. PubMed ID: 23851503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
